Skip to main content
SLU:s publikationsdatabas (SLUpub)

Forskningsartikel2009Vetenskapligt granskad

Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c

Carta, F; Maresca, A; Suarez Covarrubias, A; Mowbray, Sherry; Jones, TA; Supuran, CT


The Rv3588c gene product of Mycobacterium tuberculosis, a beta-carbonic anhydrase (CA, EC denominated here mtCA 2, shows the highest catalytic activity for CO(2) hydration (k(cat) of 9.8 x 10(5) s(-1), and k(cat)/K(m) of 9.3 x 10(7) M(1) s(1)) among the three beta-CAs encoded in the genome of this pathogen. A series of sulfonamides/sulfamates was assayed for their interaction with mtCA 2, and some diazenylbenzenesulfonamides were synthesized from sulfanilamide/metanilamide by diazotization followed by coupling with amines or phenols. Several low nanomolar mtCA 2 inhibitors have been detected among which acetazolamide, ethoxzolamide and some 4-diazenylbenzenesulfonamides (K(I)s of 9-59 nM). As the Rv3588c gene was shown to be essential to the growth of M. tuberculosis, inhibition of this enzyme may be relevant for the design of antituberculosis drugs possessing a novel mechanism of action. (C) 2009 Elsevier Ltd. All rights reserved.


Carbonic anhydrase; Mycobacterium tuberculosis; Rv3588c; Sulfonamide; Enzyme inhibitor

Publicerad i

Bioorganic and Medicinal Chemistry Letters
2009, Volym: 19, nummer: 23, sidor: 6649-6654

      SLU författare

    • Mowbray, Sherry

      • Institutionen för molekylärbiologi, Sveriges lantbruksuniversitet

    Globala målen

    SDG3 God hälsa och välbefinnande

    UKÄ forskningsämne

    Organisk kemi

    Publikationens identifierare


    Permanent länk till denna sida (URI)